$GLMD
Galmed Pharmaceuticals Ltd
PRICE
$0.4001 ▼-4.738%
Last Close
VOLUME
4,005
DAY RANGE
0.38 - 0.4251
52 WEEK
0.29 - 1.84
Key Metrics
Market Cap
10.54 M
Beta
0.30
Avg. Volume
29.29 K
Shares Outstanding
25.09 M
Yield
0%
Public Float
0
Next Earnings Date
Next Dividend Date
Company Information
Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Its lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.It is also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide and plan to initiate a first in human study by the first quarter of 2021.
CEO: Allen Baharaff
Website: galmedpharma.com
HQ: 16 Zeev Tyomkin St 4th Fl, 6578317 Tel Aviv Yafo
Related News